[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.5.192. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 1973

Thymoxamine Therapy for Angle-Closure Glaucoma

Author Affiliations

Iowa City
From the Department of Ophthalmology, glaucoma (Dr. Halasa), and neuro-ophthalmology (Dr. Rutkowski) services, University Hospitals, University of Iowa, Iowa City. Dr. Halasa is now at the American University Hospital, Beirut, Lebanon.

Arch Ophthalmol. 1973;90(3):177-179. doi:10.1001/archopht.1973.01000050179001
Abstract

Thymoxamine, an α-adrenergic blocking agent, applied topically was found to be effective in reversing an attack of angle-closure glaucoma, uncomplicated by peripheral anterior synechiae.

The rationale for using thymoxamine is based on a mathematical model explaining the mechanics of pupillary block.

The miosis produced by thymoxamine decreases the posterior vector of the force due to contraction of the sphincter, which favors pupillary block, and at the same time eliminates, by inhibition, the posterior vector of the force due to contraction of the dilator.

×